hRAD54 also has been proposed as an oncosupressor in breast cancer and several point mutations in conserved regions of the hRAD54 gene have been found in primary tumors such as colonic adenocarcinoma, non-Hodgkin lymphoma and breast carcinoma (Smirnova et al., 2004). Here, RAD54L is linked to breast cancer.